O-200 Neoadjuvant chemotherapy followed by pleuropneumonectomy for pleural mesothelioma: a multicenter phase II trial of the SAKK

MLA

Walter Weder, et al. “O-200 Neoadjuvant Chemotherapy Followed by Pleuropneumonectomy for Pleural Mesothelioma: A Multicenter Phase II Trial of the SAKK.” Lung Cancer, vol. 41, Aug. 2003, p. S59. EBSCOhost, https://doi.org/10.1016/s0169-5002(03)91858-7.

APA

Walter Weder, Peter Kestenholz, Roger Stupp, Rolf A. Stahel, Peter K. Vogt, Monika Jermann, Markus Jörger, Pierluigi Ballabeni, Daniel Betticher, & Walter Migrone. (2003). O-200 Neoadjuvant chemotherapy followed by pleuropneumonectomy for pleural mesothelioma: a multicenter phase II trial of the SAKK. Lung Cancer, 41, S59. https://doi.org/10.1016/s0169-5002(03)91858-7

Chicago

Walter Weder, Peter Kestenholz, Roger Stupp, Rolf A. Stahel, Peter K. Vogt, Monika Jermann, Markus Jörger, Pierluigi Ballabeni, Daniel Betticher, and Walter Migrone. 2003. “O-200 Neoadjuvant Chemotherapy Followed by Pleuropneumonectomy for Pleural Mesothelioma: A Multicenter Phase II Trial of the SAKK.” Lung Cancer 41 (August): S59. doi:10.1016/s0169-5002(03)91858-7.